VF
ADIL

Virtu Financial’s Adial Pharmaceuticals ADIL Stock Holding History

Virtu Financial’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,553
Closed -$14K – 1572
2025
Q4 		$14K Buy
+2,553
New +$20.7K ﹤0.01% 1476
2025
Q2 		– Sell
-1,057
Closed -$17K – 1391
2025
Q1 		$17K Buy
+1,057
New +$21.8K ﹤0.01% 1120
2024
Q2 		– Sell
-819
Closed -$27K – 1242
2024
Q1 		$27K Buy
+819
New +$30.7K ﹤0.01% 1124
2023
Q3 		– Sell
-42
Closed -$6K – 1224
2023
Q2 		$6K Sell
42
-32
-43% -$5.79K ﹤0.01% 1386
2023
Q1 		$16K Sell
74
-66
-47% -$16K ﹤0.01% 1284
2022
Q4 		$19K Buy
140
+16
+13% +$2.8K ﹤0.01% 1278
2022
Q3 		$27K Buy
124
+73
+143% +$32.9K ﹤0.01% 1338
2022
Q2 		$43K Buy
+51
New +$46.2K ﹤0.01% 1158
2021
Q3 		– Sell
-50
Closed -$79K – 1441
2021
Q2 		$79K Buy
+50
New +$76.1K 0.01% 1253
2020
Q4 		– Sell
-30
Closed -$42K – 1398
2020
Q3 		$42K Buy
+30
New +$27.9K 0.01% 842

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Virtu Financial's ADIL Position: Q1 2026 in Review

Virtu Financial sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 2,553 shares — an estimated $14K sold.

Virtu Financial first reported a position in ADIL in Q3 2020 and held it in 10 quarters. The position peaked at $79K in Q2 2021. 14 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Virtu Financial reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Virtu Financial sold 2,553 Adial Pharmaceuticals shares in Q1 2026, an estimated $14K.
  • Virtu Financial first reported a position in Adial Pharmaceuticals in Q3 2020 and held it in 10 quarters.
  • Virtu Financial's Adial Pharmaceuticals position peaked at $79K in Q2 2021.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.